EcoDrugPlus

Histone Deacetylase 1

Ensembl ID : ENSGACG00000009108
Gene Symbol: HDAC1
1 Cross references
250 Possible Orthologues:

Histone Deacetylase 1

Ensembl ID : ENSGACG00000007221
Gene Symbol: HDAC1
1 Cross references
257 Possible Orthologues:

Histone Deacetylase 10

Ensembl ID : ENSGACG00000003854
Gene Symbol: HDAC10
1 Cross references
181 Possible Orthologues:

Histone Deacetylase 11

Ensembl ID : ENSGACG00000011150
Gene Symbol: HDAC11
1 Cross references
200 Possible Orthologues:

Histone Deacetylase 3

Ensembl ID : ENSGACG00000018752
Gene Symbol: HDAC3
2 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSGACG00000002228
Gene Symbol: HDAC4
1 Cross references
202 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSGACG00000005250
Gene Symbol: HDAC5
1 Cross references
196 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSGACG00000018737
Gene Symbol: HDAC8
1 Cross references
206 Possible Orthologues:

Hypocretin (Orexin) Receptor 2

Ensembl ID : ENSGACG00000006310
Gene Symbol: HCRTR2
2 Cross references
201 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSGACG00000004136
Gene Symbol: IKBKB
1 Cross references
198 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSGACG00000003813
Gene Symbol: INPP5D
1 Cross references
216 Possible Orthologues:

Insulin Receptor A

Ensembl ID : ENSGACG00000016929
Gene Symbol: INSRA
1 Cross references
230 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).